Evidence map›Paper›PMID 23948642›Full record

Trial reportJournal of the American Heart Association2013

Simple integer risk score to determine prognosis of patients with hypertension and chronic stable coronary artery disease.

Anthony A Bavry, Dharam J Kumbhani, Yan Gong, Eileen M Handberg, Rhonda M Cooper-Dehoff, Carl J Pepine

Abstract readComparative StudyMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in Journal of the American Heart Association, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Cardiovascular Pharmacotherapy and Glucose Metabolism: The Good, the Bad and the Unsightly.American journal of cardiovascular drugs : drugs, devices, and other interventions · 2026
    Review
  3. Article
  4. Observational
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Anthony A BavryCollege of Medicine, University of Florida, Gainesville, FL.
Dharam J Kumbhani
Yan Gong
Eileen M Handberg
Rhonda M Cooper-Dehoff
Carl J Pepine

Funding

UF Clinical and Translational Science AwardUL1TR000064 · NCATS · UNIVERSITY OF FLORIDA · PI NELSON, DAVID R · 2012 to 2014
$12.2M
Metabolic Effects of Antihypertensive DrugsK23HL086558 · NHLBI · UNIVERSITY OF FLORIDA · PI COOPER-DEHOFF, RHONDA M · 2007 to 2011
$672k
NCATS NIH HHS UL1 TR000064NHLBI NIH HHS K23 HL086558
6 · The paper itself

Abstract

backgroundIt is difficult to accurately determine prognosis of patients with hypertension and chronic stable coronary artery disease (CAD). Our aim was to construct a risk score for predicting important adverse events in this population. METHODS AND

resultsPatients with hypertension and chronic stable CAD enrolled in the INternational VErapamil-SR/Trandolapril STudy (INVEST) comprised the study cohort. Candidate predictor variables were obtained from patients with at least 1 postbaseline visit. Patients were divided into development (n=18 484) and validation cohorts (n=2054). Cox regression model identified predictors of the primary outcome: all-cause mortality, myocardial infarction, or stroke at a mean follow-up of 2.3 years. The hazard ratio of each variable was rounded to the nearest integer to construct score weights. A score 0 to 4 defined low-risk, 5 to 6 intermediate-risk and ≥7 high-risk. The following variables were retained in the final model: age, residence, body mass index, on-treatment heart rate and BP, prior myocardial infarction, heart failure, stroke/transient ischemic attack, smoking, diabetes, peripheral arterial disease, and chronic kidney disease. The primary outcome occurred in 2.9% of the low-risk group, 6.5% of the intermediate-risk group, and 18.0% of the high-risk group (P for trend <0.0001). The model was good at discriminating those who had an event versus those who did not (C-statistic=0.75). The model performed well in a validation cohort (C-statistic=0.77).

conclusionReadily available clinical variables can rapidly stratify patients with hypertension and chronic stable CAD into useful risk categories.

Indexed as

Decision Support TechniquesAgedAngiotensin-Converting Enzyme InhibitorsCalcium Channel BlockersChi-Square DistributionChronic DiseaseCoronary Artery DiseaseFemaleHumansHypertensionMaleMiddle AgedMultivariate AnalysisPredictive Value of TestsPrognosisProportional Hazards ModelsAngiotensin-Converting Enzyme InhibitorsCalcium Channel Blockersclinical decision rulecoronary artery diseasecoronary heart diseaseischemic heart diseaeprognosisrisk score

Identifiers

PMID23948642
PMCPMC3828777

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.